Evidence map›Paper›PMID 28962366›Full record

ArticleToxicology reports2015

Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats.

Andrea J Moreira, Graziella Rodrigues, Silvia Bona, Carlos Thadeu Cerski, Claudio A Marroni, Jose L Mauriz, Javier González-Gallego, Norma P Marroni

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Toxicology reports · 2020
    Article
  13. Article
  14. Article
  15. Antifibrogenic effect of melatonin in rats with experimental liver cirrhosis induced by carbon tetrachloride.JGH open : an open access journal of gastroenterology and hepatology · 2018
    Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Andrea J MoreiraCenter of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Graziella RodriguesCenter of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Silvia BonaCenter of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Carlos Thadeu CerskiCenter of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Claudio A MarroniCenter of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Jose L MaurizCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) and Institute of Biomedicine (IBIOMED), University of León, León, Spain.
Javier González-GallegoCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) and Institute of Biomedicine (IBIOMED), University of León, León, Spain.
Norma P MarroniCenter of Experimental Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Universidade Federal do Rio Grande do Sul · BRCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer deaths throughout the world. This study was aimed to analyze oxidative stress and cell damage in a multistage model of liver carcinogenesis induced by diethylnitrosamine (DEN) in rats. Male Wistar rats weighing 145-150 g were divided into three groups: control, precancerous lesions (PL) (which received 100 mg DEN once a week every 6 weeks up to 28 weeks), and advanced HCC (50 mg DEN once/twice per week up to 19 weeks). Lipid peroxidation (TBARS), superoxide dismutase (SOD) activity, and expression of transforming growth factor-1 beta (TGF)-1β, endothelial and inducible nitric oxide syntahese (eNOS, iNOS), NADPH quinone oxireductase (NQO)-1, nuclear factor erythroid 2-related factor (NrF)2, kelch-like ECH-associated protein (Keap)1 and heat shock protein (HSP)70 were measured. TBARS concentration was augmented in the PL and advanced HCC groups. SOD activity, TGF-1β and Nrf2 expression were higher in animals with precancerous lesions. In advanced HCC, expression of NQO1 and iNOS increased while there was a decrease in HPS70 expression. Data obtained provide evidence for the differential activation of proteins involved in oxidative stress and cell damage during progression of carcinogenesis in an animal model of HCC.

Indexed as

2-AAF, 2-acetylaminofluoreneALT, alanine aminotransferaseAP, alkaline phosphataseAST, aspartate aminotransferaseDEN, diethylnitrosamineDiethylnitrosamineEDTA, ethylenediamine tetraacetic acideNOS, endothelial nitric oxide synthaseGGT, gamma-glutamyl transferaseHCC, hepatocellular carcinomaHeat shock proteinHepatocarcinomaHSC, hepatic stellate cellsHSP70, heat shock 70-kDa proteiniNOS, inducible nitric oxide synthaseKeap1, kelch-like ECH-associated protein 1MDA, malonaldehydeNitric oxide synthaseNO, nitric oxideNQO1, NADPH quinone oxireductase-1Nrf2, nuclear factor erythroid 2-related factor 2Nuclear factor erythroid 2-related factor 2Oxidative stressPVDF, polyvinylidene fluorideSOD, superoxide dismutaseTBARS, thiobarbituric acid reactant substancesTGF-1β, transforming growth fator-1 betaTTBS, Tris-buffered containing 0.05% Tween 20UV, ultra violet

Identifiers

PMID28962366
PMCPMC5598147
OpenAlexW1966604963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.